Biogen bets more on Isis technology for neurological drugs

The company's name is displayed on a billboard near the headquarters of Biogen Idec Inc. in CambridgeBy Deena Beasley (Reuters) – Biogen Idec has agreed to pay another $100 million upfront to Isis Pharmaceuticals Inc as part of a broad collaboration to develop new medicines for neurological disorders, the companies said on Monday. The news sent Isis's shares up 9 percent in premarket trade. The deal is the fourth between the companies in the last two years, and aims to use the "antisense" technology invented by Isis to accelerate discovery of drug targets for neurodegenerative diseases. …

Oncolytics lung cancer drug shrinks tumors in 92 percent of patients in trial

(Reuters) – Oncolytics Biotech Inc said its cancer drug Reolysin reduced the size of tumors in 92 percent of lung cancer patients in a mid-stage trial. The company’s shares rose as much as 22 percent to $3.22 in trading before the bell. The drug was tested on patients suffering from advanced squamous cell carcinoma of the lung. It was used intravenously in combination with chemotherapy drugs carboplatin and paclitaxel. …

Groups race to hire, train ‘Obamacare’ guides

In this Sept. 5, 2013, Jacqueline Saulsberry, a service coordinator at the Illinois Eye Institute, gathers information from patient Shameka Lewis-Coolidge during an appointment in Chicago. With the program known as "Obamacare" only weeks away from its key launch date, hectic preparations are now in motion in communities across the country to deal with one of its major practical challenges: hiring and training a small army of instant experts who can explain the intricacies of health insurance to people who’ve never had it. More than 100 nonprofits and related organizations have been recruited by the federal government to sign up “navigators” who can help the 30 million uninsured people who can now gain coverage. (AP Photo/M. Spencer Green)CHICAGO (AP) — With the program known as "Obamacare" only weeks away from its key launch date, hectic preparations are in motion in communities across the country to deal with one of its major practical challenges: hiring and training a small army of instant experts who can explain the intricacies of health insurance to people who've never had it.

Insight: Research renaissance offers new ways out of depression

File photo of Prozac medicine seen at a pharmacy in Los AngelesBy Kate Kelland, Health and Science Correspondent LONDON (Reuters)- As Susan sits chatting to a nurse in a London clinic, a light tapping sound by her head signals that parts of her brain are being zapped by thousands of tiny electro-magnetic pulses from a machine plugged into the wall. The 50 year-old doctor is among growing ranks of people with so-called treatment-resistant depression, and after 21 years fighting a disorder that destroyed her ability to work and at times made her want to "opt out of life", this is a last resort. …

Norway’s opposition set for sweeping election victory

Norway's Prime Minister Jens Stoltenberg and main opposition leader Erna Solberg leave a building after an appeareance on a television show in OsloBy Balazs Koranyi OSLO (Reuters) – Norway's center-right opposition, pledging privatization, tax cuts and smaller government, was set for a sweeping election win on Monday but faces difficult coalition talks since a populist anti-immigration party will hold the balance of power. Norway has enjoyed rare economic success, thanks to its flourishing offshore oil sector boosting per capita GDP to $100,000. But growth is slowing and voters are ready to punish Labour Prime Minister Jens Stoltenberg, accusing him of wasting a once-in-a-lifetime economic boom. …

1 89 90 91 92 93 99